Literature DB >> 25414259

MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor (MITF) mRNA is inhibited by coding region determinant-binding protein (CRD-BP).

Srikanta Goswami1, Rohinton S Tarapore2, Ashley M Poenitzsch Strong2, Jessica J TeSlaa3, Yevgenya Grinblat4, Vijayasaradhi Setaluri1, Vladimir S Spiegelman5.   

Abstract

Alternative cleavage and polyadenylation generates multiple transcript variants producing mRNA isoforms with different length 3'-UTRs. Alternative cleavage and polyadenylation enables differential post-transcriptional regulation via the availability of different cis-acting elements in 3'-UTRs. Microphthalmia-associated transcription factor (MITF) is a master regulator of melanocyte development and melanogenesis. This central transcription factor is also implicated in melanoma development. Here, we show that melanoma cells favor the expression of MITF mRNA with a shorter 3'-UTR. We also establish that this isoform is regulated by a micro RNA (miRNA/miR), miR-340. miR-340 interacts with two of its target sites on the MITF 3'-UTR, causing mRNA degradation as well as decreased expression and activity of MITF. Conversely, the RNA-binding protein, coding region determinant-binding protein, was shown to be highly expressed in melanoma, directly binds to the 3'-UTR of MITF mRNA, and prevents the binding of miR-340 to its target sites, resulting in the stabilization of MITF transcripts, elevated expression, and transcriptional activity of MITF. This regulatory interplay between RNA-binding protein and miRNA highlights an important mechanism for the regulation of MITF in melanocytes and malignant melanomas.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Alternative Cleavage and Polyadenylation; CRD-BP; IGF2BP1; MITF; Melanogenesis; Melanoma; MicroRNA (miRNA); Ribonuclear Protein (RNP); mRNA; mRNA Decay; miRNA

Mesh:

Substances:

Year:  2014        PMID: 25414259      PMCID: PMC4281741          DOI: 10.1074/jbc.M114.590158

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  RNA-binding IMPs promote cell adhesion and invadopodia formation.

Authors:  Jonas Vikesaa; Thomas V O Hansen; Lars Jønson; Rehannah Borup; Ulla M Wewer; Jan Christiansen; Finn C Nielsen
Journal:  EMBO J       Date:  2006-03-16       Impact factor: 11.598

2.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells.

Authors:  Margaret S Ebert; Joel R Neilson; Phillip A Sharp
Journal:  Nat Methods       Date:  2007-08-12       Impact factor: 28.547

3.  Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites.

Authors:  Rickard Sandberg; Joel R Neilson; Arup Sarma; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2008-06-20       Impact factor: 47.728

Review 4.  Interplay between microRNAs and RNA-binding proteins determines developmental processes.

Authors:  Martijn Kedde; Reuven Agami
Journal:  Cell Cycle       Date:  2008-01-24       Impact factor: 4.534

Review 5.  MITF: master regulator of melanocyte development and melanoma oncogene.

Authors:  Carmit Levy; Mehdi Khaled; David E Fisher
Journal:  Trends Mol Med       Date:  2006-08-08       Impact factor: 11.951

6.  CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling.

Authors:  Felicite K Noubissi; Irina Elcheva; Neehar Bhatia; Abbas Shakoori; Andrei Ougolkov; Jianghuai Liu; Toshinari Minamoto; Jeff Ross; Serge Y Fuchs; Vladimir S Spiegelman
Journal:  Nature       Date:  2006-06-15       Impact factor: 49.962

7.  MicroRNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma.

Authors:  Ashley M Poenitzsch Strong; Vijayasaradhi Setaluri; Vladimir S Spiegelman
Journal:  Arch Biochem Biophys       Date:  2014-07-17       Impact factor: 4.013

8.  The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Genes Dev       Date:  2007-04-16       Impact factor: 11.361

9.  Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation.

Authors:  Christine Mayr; Michael T Hemann; David P Bartel
Journal:  Science       Date:  2007-02-22       Impact factor: 47.728

10.  MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines.

Authors:  Lynne T Bemis; Robert Chen; Carol M Amato; Elizabeth H Classen; Steven E Robinson; David G Coffey; Paul F Erickson; Yiqun G Shellman; William A Robinson
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

View more
  22 in total

1.  The mRNA-binding protein IGF2BP1 maintains intestinal barrier function by up-regulating occludin expression.

Authors:  Vikash Singh; Chethana P Gowda; Vishal Singh; Ashwinkumar S Ganapathy; Dipti M Karamchandani; Melanie A Eshelman; Gregory S Yochum; Prashant Nighot; Vladimir S Spiegelman
Journal:  J Biol Chem       Date:  2020-05-08       Impact factor: 5.157

2.  Protein kinase C-α is upregulated by IMP1 in melanoma and is linked to poor survival.

Authors:  Lily Mahapatra; Neal Andruska; Chengjian Mao; Stephen B Gruber; Timothy M Johnson; Douglass R Fullen; Leon Raskin; David J Shapiro
Journal:  Melanoma Res       Date:  2019-10       Impact factor: 3.599

3.  miR-148 regulates Mitf in melanoma cells.

Authors:  Benedikta S Haflidadóttir; Kristín Bergsteinsdóttir; Christian Praetorius; Eiríkur Steingrímsson
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

4.  miFAST: A novel and rapid microRNA target capture method.

Authors:  Ashley M Poenitzsch Strong; Scott M Berry; David J Beebe; Jian-Liang Li; Vladimir S Spiegelman
Journal:  Mol Carcinog       Date:  2018-02-12       Impact factor: 4.784

Review 5.  RNA Binding Proteins in the miRNA Pathway.

Authors:  Patrick Connerty; Alireza Ahadi; Gyorgy Hutvagner
Journal:  Int J Mol Sci       Date:  2015-12-26       Impact factor: 5.923

6.  Systems analysis identifies miR-29b regulation of invasiveness in melanoma.

Authors:  Miles C Andrews; Joseph Cursons; Daniel G Hurley; Matthew Anaka; Jonathan S Cebon; Andreas Behren; Edmund J Crampin
Journal:  Mol Cancer       Date:  2016-11-16       Impact factor: 27.401

7.  MicroRNA-340 inhibits the proliferation and promotes the apoptosis of colon cancer cells by modulating REV3L.

Authors:  Roshini Arivazhagan; Jaesuk Lee; Delger Bayarsaikhan; Peter Kwak; Myeongjoo Son; Kyunghee Byun; Ghasem Hosseini Salekdeh; Bonghee Lee
Journal:  Oncotarget       Date:  2017-12-26

Review 8.  microRNAs in the Regulation of Melanogenesis.

Authors:  Yekatsiaryna Hushcha; Irene Blo; Lucia Oton-Gonzalez; Giulia Di Mauro; Fernanda Martini; Mauro Tognon; Monica De Mattei
Journal:  Int J Mol Sci       Date:  2021-06-05       Impact factor: 5.923

Review 9.  IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer.

Authors:  Nils Degrauwe; Mario-Luca Suvà; Michalina Janiszewska; Nicolo Riggi; Ivan Stamenkovic
Journal:  Genes Dev       Date:  2016-11-15       Impact factor: 11.361

Review 10.  RNA Secondary Structure Modulates FMRP's Bi-Functional Role in the MicroRNA Pathway.

Authors:  Phillip Kenny; Stephanie Ceman
Journal:  Int J Mol Sci       Date:  2016-06-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.